To the Editor: Poisonings due to wild mushrooms have been known since ancient times; the fi rst death as a result of their toxicity was described 450 years BC, and since then we have identifi ed more than 5000 diff erent kinds of mushrooms, with hundreds of them registered test probability of a positive diagnosis aft er a negative test is ( 3 ):
where p 0 and p 1 represent the pre-and posttest disease probability, respectively, and FN=(1 − sensitivity) and TN=specifi city, represent the false negative and true negative test fractions, respectively. Aft er multiple ( i ) consecutive tests have been performed, the formula from above for the post-test probability changes to:
Th e Π symbol indicates the product of all FN i and TN i values associated with the individual testes. With increasing number of negative tests, the probability p i for fi nding a positive diagnosis declines. Th e right side of Figure 1 depicts the falling expected cost of a missed diagnosis p i ($Dx − $Rx) in relation to the test costs ($TC). In plotting the fi gure, it was arbitrarily assumed that for each test alike sensitivity=specifi city=70% and ($Dx − $Rx)= 10· $TC. In the example shown on the right side of Figure 1 , the tests costs start exceeding the expected costs of missed diagnosis aft er the eighth test, when further testing should be abandoned. Because, in reality consecutive tests will vary with respect to their individual sensitivity and specifi city values, the expected the potential benefi t of a precise diagnosis. Similar dilemmas arise in the workup of long-standing abdominal pain or intermittent diarrhea. Th e gastroenterologist is faced with the decision when to end the search for an elusive gastrointestinal diagnosis ( 2 ).
(Th e previous analysis of the problem contained an erroneous Bayes' formula, used cumulative rather than marginal test costs to specify the end-point of testing, and mixed costs and benefi ts within the same decision tree. Th is letter partly serves to rectify these mistakes.)
In general, any decision in favor of performing a test is associated with costs for the test itself ($TC) and potential costs for therapy ($Rx), once a diagnosis is found, as shown in the upper branch of the decision tree in Figure 1 . Th e decision against performing a test (lower branch of the decision tree) results in the potential costs of a missed diagnosis ($Dx). Th e value p represents the probability for the presence of a diagnosis. Testing is done as long as the costs of the upper branch are less than those of the lower branch:
For testing to continue, its costs need to be less than the potential cost diff erence of diagnosis and therapy. Th e probability of a major relevant diagnosis p , declines with the number of consecutive negative tests. Bayes formula for the revised post- four of them needed treatment with hemodialysis. All of them had fatal ending, due to multisystem organ failure. Due to liver and renal failure the majority of patients have had pathologic laboratory fi ndings. Th e last phase of the intoxication is characterized by multi-systemic organ failure, which may lead to death within the fi rst 3 weeks aft er ingestion. Th e highest mortality rate was recorded among children under the age of 10 and among patients older than 50 years ( 5, 6 ) . Clinical toxicologists, together with specialists in mycology, accent the importance of specialized education for mushrooms in order to stop the growth, collection and consumption of wild mushrooms by people who are not experts in this fi eld. We also need good educational programs, strategies in the healthcare system for a better treatment of these poisonings, and experimental studies for identifi cation of mushrooms in order to approve their recognition and to maintain further appropriate clinical treatment.
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cessing, special preparation, or addition of spices. Incubation can be very short (<6 h) but in some patients it can be very long (>30 h) ( 3, 4 ) .
We present results from a group of 92 patients who were hospitalized and treated at our clinic ( Table 1 ) . Clinical records from a 10-year period were collected and completely analyzed. We registered various parameters, with greatest attention on clinical presentation, complication, and occurrence of acute liver and renal failure. Usually patients did not have specimens of the mushrooms they ingested, but they always described their characteristics. We tried to identify them properly according to the symptoms developed and by consulting an expert from the Faculty of Agriculture And Food. We could surely identify the mushrooms in 25 patients. Most of the patients had mild gastrointestinal symptoms ( n =87) and some of them developed acute liver failure ( n =49). Acute renal failure was seen in fi ve patients, and as poisonous . Ingestion of several types of wild mushrooms can lead to an urgent clinical state and development of various symptoms of which the most dangerous are severe impairment in renal and liver functions ( 1, 2 ) .
Intoxication with wild mushrooms is a globally known medical issue, and the biggest problem related to them is their delayed diagnosis due to several characteristics-late identifi cation of mushrooms that have been consumed, confusing clinical presentations and incomplete information given by patients. Poisonings due to wild mushrooms have an annual distribution, and are usually seen during certain months; most commonly they occur during the months of October and November and among members of one family. All mushrooms in nature can be easily reached by humans; the poisonous and eatable types grow together near populated areas. Wild mushrooms with toxic properties cannot be detoxifi ed aft er thermic pro- 
